Product record
Olmesartan Medoxomil Chlorthalidone Clinidipine: batches declared Not of Standard Quality
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts, Jan 2019 to Sep 2026
1 batch of products named "Olmesartan Medoxomil Chlorthalidone Clinidipine" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test in September 2026. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.
Records by type
1 record linked to Olmesartan Medoxomil Chlorthalidone Clinidipine in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches
| Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Batch LMT26074Mfg Feb 2026 · Exp Jan 2028 | Alwashank Life Max Cancer LaboratoriesUttarakhand | The Content of Cilnidipine in the Sample is less i.e. 51.80% of Stated Amount) than Schedule V Limit. (Schedule V Limit:- Not less than 90% and Not More than 110% of Stated Amount)Other | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab | Sep 2026 |
How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of September 2026. Check any batch number.